Initial orders of the Genedrive MT-RNR1 Products for new sites in the UK
Genedrive PLC (AIM:GDR) Proposed REX Retail Offer
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, today announces its intention to raise funds by means of a proposed retail offer via the Retail Capital Markets ‘REX’ portal (the
Genedrive PLC (AIM:GDR) NICE recommends the Genedrive CYP2C19-ID Kit
NICE recommends the Genedrive® CYP2C19-ID Kit